Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pelargonidin is a naturally occurring **anthocyanidin**—a plant pigment notably responsible for orange to red colors in various flowers and fruits. It belongs to the flavonoid class, specifically 7-hydroxyflavonoids, and contains hydroxy groups at the 3, 5, 7, and 4' positions of the flavylium backbone[1][5][7]. **Pelargonidin is primarily found in red geraniums, and fruits such as strawberries, black raspberries, radishes, and sour cherries**[1][7]. It serves as a plant metabolite with notable **antioxidant properties** and has been studied for potential antidiabetic and anticancer effects, mainly through radical scavenging and inhibition of reactive oxygen species, though it is not an approved pharmaceutical drug[2]. Its mechanism of action is primarily related to non-specific antioxidant activity and possibly the inhibition of enzymes like nitric oxide synthase (NOS)[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pelargonidin.